GALT vs REGN: Which Stock is Better?

Side-by-side comparison of Galectin Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

GALT

Galectin Therapeutics Inc

$2.45

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricGALTREGNWinner
Market Cap$161.28M$79.35BREGN
P/E RatioN/A18.08REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze GALT

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is GALT or REGN a better investment?

Comparing GALT and REGN: Galectin Therapeutics Inc has a market cap of $161.28M while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between GALT and REGN?

GALT (Galectin Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: GALT or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: GALT or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for GALT.

Which company is more profitable: GALT or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for GALT.

Which is the larger company: GALT or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $161.28M for GALT.

Should I buy GALT or REGN in 2026?

Both GALT and REGN have investment merit. GALT trades at $2.45 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between GALT and REGN stock?

Key differences: Market Cap ($161.28M vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons